Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.
Meyer T, Maier A, Uzelac Z, Hagenacker T, Günther R, Schreiber-Katz O, Weiler M, Steinbach R, Weyen U, Koch JC, Kettemann D, Norden J, Dorst J, Wurster C, Ludolph AC, Stolte B, Freigang M, Osmanovic A, Petri S, Grosskreutz J, Rödiger A, Griep R, Gaudlitz M, Walter B, Münch C, Spittel S. Meyer T, et al. Among authors: uzelac z. Eur J Neurol. 2021 Aug;28(8):2582-2595. doi: 10.1111/ene.14902. Epub 2021 Jun 16. Eur J Neurol. 2021. PMID: 33960080
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.
Wurster CD, Günther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z, Witzel S, Kocak T, Winter B, Koch JC, Lingor P, Petri S, Ludolph AC, Hermann A, Otto M. Wurster CD, et al. Among authors: uzelac z. Ther Adv Neurol Disord. 2019 May 10;12:1756286419846058. doi: 10.1177/1756286419846058. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31205491 Free PMC article.
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
Wurster CD, Steinacker P, Günther R, Koch JC, Lingor P, Uzelac Z, Witzel S, Wollinsky K, Winter B, Osmanovic A, Schreiber-Katz O, Al Shweiki R, Ludolph AC, Petri S, Hermann A, Otto M; MND-Net. Wurster CD, et al. Among authors: uzelac z. J Neurol. 2020 Jan;267(1):36-44. doi: 10.1007/s00415-019-09547-y. Epub 2019 Sep 24. J Neurol. 2020. PMID: 31552549
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.
Wurster CD, Koch JC, Cordts I, Dreyhaupt J, Otto M, Uzelac Z, Witzel S, Winter B, Kocak T, Schocke M, Weydt P, Wollinsky K, Ludolph AC, Deschauer M, Lingor P, Tumani H, Hermann A, Günther R. Wurster CD, et al. Among authors: uzelac z. Front Neurol. 2019 Nov 7;10:1179. doi: 10.3389/fneur.2019.01179. eCollection 2019. Front Neurol. 2019. PMID: 31787927 Free PMC article.
Quality of Life in SMA Patients Under Treatment With Nusinersen.
Mix L, Winter B, Wurster CD, Platen S, Witzel S, Uzelac Z, Graf H, Ludolph AC, Lulé D. Mix L, et al. Among authors: uzelac z. Front Neurol. 2021 Mar 29;12:626787. doi: 10.3389/fneur.2021.626787. eCollection 2021. Front Neurol. 2021. PMID: 33854472 Free PMC article.
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.
Binz C, Osmanovic A, Thomas NH, Stolte B, Freigang M, Cordts I, Griep R, Uzelac Z, Wurster CD, Kamm C, Siegler HA, Wieselmann G, Hermann A, Lingor P, Deschauer M, Ludolph AC, Meyer T, Günther R, Hagenacker T, Petri S, Schreiber-Katz O. Binz C, et al. Among authors: uzelac z. Ann Clin Transl Neurol. 2022 Mar;9(3):351-362. doi: 10.1002/acn3.51520. Epub 2022 Feb 22. Ann Clin Transl Neurol. 2022. PMID: 35191616 Free PMC article.
35 results